BBL
AMED icon

Beck Bode LLC’s Amedisys AMED Stock Holding History

Beck Bode LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-136
Closed -$32K – 16
2020
Q3 		$32K Sell
136
-33,990
-100% -$7.73M 0.01% 132
2020
Q2 		$6.78M Buy
34,126
+2,246
+7% +$419K 2.78% 20
2020
Q1 		$5.87M Buy
31,880
+12,854
+68% +$2.29M 2.7% 22
2019
Q4 		$3.18M Sell
19,026
-114
-0.6% -$17K 1.3% 31
2019
Q3 		$2.51M Buy
+19,140
New +$2.49M 1.1% 33

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Beck Bode LLC's AMED Position: Q4 2020 in Review

Beck Bode LLC sold out of Amedisys (AMED) in Q4 2020, closing a stake of 136 shares — an estimated $32K sold.

Beck Bode LLC first reported a position in AMED in Q3 2019 and held it in 5 quarters. The position peaked at $6.78M in Q2 2020. 398 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Beck Bode LLC reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Beck Bode LLC sold 136 Amedisys shares in Q4 2020, an estimated $32K.
  • Beck Bode LLC first reported a position in Amedisys in Q3 2019 and held it in 5 quarters.
  • Beck Bode LLC's Amedisys position peaked at $6.78M in Q2 2020.
  • 398 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Beck Bode LLC's 13F filing for Q4 2020.